Initially, increased lncARSR expression was found in oleate-treated HepG2 cells and HFD-fed mice, suggesting that lncARSR may be associated with the progression of NAFLD. This evidence concerns the gene LNCARSR and metabolic dysfunction-associated steatotic liver disease.